India: MedGenome raises US$55m Series D funding

Sam Santhosh, chief executive and founder, MedGenome

MedGenome, the largest provider of genomic solutions for populations in South Asia and emerging markets, has raised US$55m Series D funding led by LeapFrog Investments. Existing investors Sofina and Sequoia also participated in the round. The company has now raised US$119m in six rounds according to CrunchBase. “Genomics and personalised medicine are the future of…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »